OTC Markets EXMKT - Delayed Quote USD

Deltagen Inc. (DGEN)

Compare
0.0001 0.0000 (0.00%)
At close: October 25 at 4:00 PM EDT
Loading Chart for DGEN
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0001
  • Volume 6,430
  • Avg. Volume 0
  • Market Cap (intraday) 2.746M
  • Beta (5Y Monthly) -214.05
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 17, 2007
  • 1y Target Est --

Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.

www.deltagen.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DGEN

View More

Research Reports: DGEN

View More

Performance Overview: DGEN

Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

DGEN
0.00%
S&P 500
21.77%

1-Year Return

DGEN
0.00%
S&P 500
36.74%

3-Year Return

DGEN
0.00%
S&P 500
27.79%

5-Year Return

DGEN
0.00%
S&P 500
92.94%

Compare To: DGEN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DGEN

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.97%

  • Return on Assets (ttm)

    -1.58%

  • Return on Equity (ttm)

    -2.72%

  • Revenue (ttm)

    770k

  • Net Income Avi to Common (ttm)

    -46k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    23k

  • Total Debt/Equity (mrq)

    1.46%

  • Levered Free Cash Flow (ttm)

    66.25k

Research Analysis: DGEN

View More

Company Insights: DGEN

People Also Watch